Project Details
Description
A Phase 3, Multicenter, Open-Label Extension Study of Patidegib Topical Gel, 2% in Subjects with Gorlin Syndrome (Basal Cell Nevus Syndrome)
| Status | Active |
|---|---|
| Effective start/end date | 5/18/20 → 5/31/25 |
Funding
- PELLEPHARM, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.